Nouso K - Search Results

1

Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.

Rimini M, Persano M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Salani F, Lonardi S, Piscaglia F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Schirripa M, Montes M, Vivaldi C, Soldà C, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Burgio V, Scartozzi M, Cascinu S, Casadei-Gardini A. Rimini M, et al. Among authors: nouso k. J Cancer Res Clin Oncol. 2023 Aug;149(10):7565-7577. doi: 10.1007/s00432-023-04678-2. Epub 2023 Mar 28. J Cancer Res Clin Oncol. 2023. PMID: 36976353

2

Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region.

Alam SS, Nakamura T, Naganuma A, Nozaki A, Nouso K, Shimomura H, Kato N. Alam SS, et al. Among authors: nouso k. Acta Med Okayama. 2002 Jun;56(3):141-7. doi: 10.18926/AMO/31716. Acta Med Okayama. 2002. PMID: 12108585 Free article.

3

Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma.

Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, Higashi T, Ono T, Nakayama E, Hanafusa T, Shiratori Y. Uemura M, et al. Among authors: nouso k. Cancer. 2003 May 15;97(10):2474-9. doi: 10.1002/cncr.11374. Cancer. 2003. PMID: 12733146 Free article.

4

Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.

Uematsu S, Higashi T, Nouso K, Kariyama K, Nakamura S, Suzuki M, Nakatsukasa H, Kobayashi Y, Hanafusa T, Tsuji T, Shiratori Y. Uematsu S, et al. Among authors: nouso k. J Gastroenterol Hepatol. 2005 Apr;20(4):583-8. doi: 10.1111/j.1440-1746.2005.03726.x. J Gastroenterol Hepatol. 2005. PMID: 15836707

5

Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival.

Tanaka H, Nouso K, Kobashi H, Kobayashi Y, Nakamura S, Miyake Y, Ohnishi H, Miyoshi K, Iwado S, Iwasaki Y, Sakaguchi K, Shiratori Y. Tanaka H, et al. Among authors: nouso k. Liver Int. 2006 Jun;26(5):543-51. doi: 10.1111/j.1478-3231.2006.01270.x. Liver Int. 2006. PMID: 16761998

6

Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.

Nouso K, Tanaka H, Uematsu S, Shiraga K, Okamoto R, Onishi H, Nakamura S, Kobayashi Y, Araki Y, Aoki N, Shiratori Y. Nouso K, et al. J Gastroenterol Hepatol. 2008 Mar;23(3):437-44. doi: 10.1111/j.1440-1746.2007.05054.x. Epub 2007 Aug 6. J Gastroenterol Hepatol. 2008. PMID: 17683496

7

Twist expression promotes migration and invasion in hepatocellular carcinoma.

Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Matsuo N, et al. Among authors: nouso k. BMC Cancer. 2009 Jul 18;9:240. doi: 10.1186/1471-2407-9-240. BMC Cancer. 2009. PMID: 19615090 Free PMC article.

8

Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma.

Iwadou S, Nouso K, Kuwaki K, Kobayashi Y, Nakamura S, Tanaka H, Miyoshi K, Ohnishi H, Miyake Y, Shiraha H, Iwasaki Y, Shiratori Y, Yamamoto K. Iwadou S, et al. Among authors: nouso k. Liver Int. 2010 Aug;30(7):1027-32. doi: 10.1111/j.1478-3231.2010.02252.x. Epub 2010 May 18. Liver Int. 2010. PMID: 20492506

9

Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma.

Ohnishi H, Sakaguchi K, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Miyake Y, Shoji B, Iwadou S, Shiratori Y. Ohnishi H, et al. Among authors: nouso k. Hepatol Int. 2010 Jul 25;4(3):562-8. doi: 10.1007/s12072-010-9190-6. Hepatol Int. 2010. PMID: 21063478 Free PMC article.

10

Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.

Hagihara H, Nouso K, Kobayashi Y, Iwasaki Y, Nakamura S, Kuwaki K, Toshimori J, Miyatake H, Ohnishi H, Shiraha H, Yamamoto K. Hagihara H, et al. Among authors: nouso k. Int J Clin Oncol. 2011 Jun;16(3):210-20. doi: 10.1007/s10147-010-0150-x. Epub 2010 Dec 9. Int J Clin Oncol. 2011. PMID: 21152943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters